Alamar Biosciences (ALMR) vs EyePoint (EYPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.80 billion vs $290.1 million), about 6.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | EYPT |
|---|---|---|
| Share price | $25.91 | $3.46 |
| Market cap | $1.80B | $290.09M |
| 1-day change | -6.70% | +4.22% |
| YTD return | — | -81.06% |
| 1-year return | — | -75.07% |
| 5-year return | — | -69.76% |
| EPS (TTM) | $-1.20 | $-3.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.61 | $19.11 |
| 52-week low | $18.85 | $3.05 |
| Distance from 52-week high | -34.59% | -81.89% |
| Analyst consensus | buy | none |
| Avg. price target upside | +36.63% | +648.84% |
| Average volume | 411.15K | 3.96M |
| Shares outstanding | 69.39M | 83.84M |
| Employees | 286 | 214 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 6.2 times larger than EyePoint by market value ($1.80B vs $290.09M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
ALMR vs EYPT FAQ
Which is bigger, Alamar Biosciences or EyePoint?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.80B compared with $290.09M for EyePoint (EYPT).
Are Alamar Biosciences and EyePoint in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.